SIRT1 knockdown decreased migration and invasion of HCC cells in vitro, decreased HCC invasion and metastasis in vivo (45, 54), and impaired mitochondrial function and biogenesis, suggesting that the SIRT1/PGC-1α axis may be a viable therapeutic target for decreasing metastasis (54). Here, SIRT1 is linked to hepatocellular carcinoma.